Trifermed

We build strategic partnership systems based on the ability to sustain future adoption of health innovation.

Because health innovation does not fail only at the level of product, science, funding or regulation. It often fails when the path to adoption is not structurally defined.

01 / The shift

THE CRITICAL SHIFT

Most partnership strategies focus on:

Capabilities

Traditional partnership evaluation often prioritises execution capability: what a partner can operationally deliver within a specific stage or function.

Geography

Regional presence and territorial reach are frequently used as indicators of strategic fit and commercial expansion potential.

Commercial Reach

Evaluation commonly focuses on sales infrastructure, distribution capacity and market penetration capabilities.

Development Capacity

Partnership logic often prioritises operational scale, technical infrastructure and development acceleration potential.

Regulatory Expertise

Regulatory strength is traditionally evaluated as a key capability to navigate approval pathways and compliance requirements.

Market Access Expertise

Many evaluations focus on reimbursement access, payer engagement and commercial adoption infrastructure.

But they often miss the decisive question:

Can this partner sustain how the innovation will eventually be adopted?

02 / The view

THE TRIFERMED VIEW

The partner is not a channel.

The partner is part of the adoption architecture.

A strong partner is not only able to execute a phase, open a market or fund development.

A strong partner understands, supports and strengthens the conditions under which the innovation can become adopted in real healthcare systems.

03 / The adoption system

WHAT ADOPTION REALLY DEPENDS ON

Adoption is not a single decision.

It emerges through the interaction of:

Without alignment across these layers, adoption does not hold.

Clinical pathways

Healthcare organisations

Practitioners

Patients

Procurement structures

Reimbursement logic

Regulatory frameworks

Standards of care

04 / The work

WHAT WE DO

We design and validate the logic by which strategic partners are selected, structured and engaged.

Not only based on what they can do.

But based on whether they can sustain the future adoption of the innovation.

This applies across early development, clinical phases, market readiness and international expansion.

Adoption is not a final stage.

It is a strategic condition that must be considered from the beginning.

05 / The system

A SYSTEM, NOT A PROMISE

Trifermed has translated more than two decades of experience into a structured partnership system.

The system combines:

01

Strategic hypothesis design

02

Market and partner validation

03

Real-world stakeholder engagement

04

AI-supported project orchestration

05

Partnership structuring and execution

Its purpose is not to create activity.

Its purpose is to reduce uncertainty before strategic decisions are made.

06 / The actors

WHO WE WORK WITH

We work with organisations that grow through strategic partnerships.

HEALTH INNOVATORS

Developing technologies, products or platforms that require the right partners to move forward.

COMMERCIAL ORGANISATIONS

Seeking external innovation, portfolio evolution or international expansion.

INVESTORS

Looking for clearer strategic validation of health innovation opportunities.

Across all three, the question is the same:

What partnership system can sustain future adoption?

07 / The position

THIS IS US

Trifermed is a strategic partnership company operating at the intersection of health innovation, global markets and real-world adoption.

We are not a consulting firm, not brokers and not an investment bank. Our role is to help organisations make better partnership decisions when uncertainty is high, adoption is complex and execution requires alignment across multiple layers.

We work where strategic intent must become structured action.

08 / The human layer

PEOPLE BEHIND THE SYSTEM

The Trifermed system is built on more than two decades of experience engaging companies, innovators, investors and stakeholders across global health ecosystems.

Behind the system is a team with long-term exposure to the realities of health innovation: scientific complexity, commercial pressure, regulatory uncertainty, market fragmentation and the challenge of making innovation adoptable in real-world contexts.

This experience informs how Trifermed designs, validates and structures partnership systems.

09 / The movement

TRIFERMED IS PART OF EIRA

EIRA is a broader movement focused on how health innovation translates into real-world impact.

Within that movement, Trifermed acts as a strategic engine: working where adoption logic, partnership systems and real-world execution must connect.